# The Effect of Soluble Epoxide Hydrolase (SEH) on Depression

> **NCT05575713** · — · COMPLETED · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 330 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05575713
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-01
- **Primary completion:** 2024-10-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2024-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05575713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05575713, "The Effect of Soluble Epoxide Hydrolase (SEH) on Depression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05575713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
